Biocartis Group Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 420

Employees

  • Latest Deal Type
  • Liquidation

Biocartis Group General Information

Description

Developer of a molecular diagnostics platform designed to support cancer diagnosis and treatment decisions. The company's platform offers molecular diagnostic testing, oncology-focused biomarker analysis, and automated testing capabilities, enabling healthcare providers and clinical laboratories to improve diagnostic accuracy and support personalized cancer care.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Generaal De Wittelaan 11B
  • 2800 Mechelen
  • Belgium
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Generaal De Wittelaan 11B
  • 2800 Mechelen
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocartis Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Bankruptcy: Liquidation 15-Dec-2025 Completed Bankruptcy: Liquidation
17. PIPE 29-Nov-2022 Completed Generating Revenue
16. PIPE 23-Jan-2019 Completed Generating Revenue
15. Debt - General 28-Feb-2018 Completed Generating Revenue
14. PIPE 28-Nov-2017 Completed Generating Revenue
13. PIPE 01-Jun-2017 Completed Generating Revenue
12. PIPE 17-Nov-2016 Completed Generating Revenue
11. IPO 27-Apr-2015 Completed Generating Revenue
10. Accelerator/Incubator $337M Completed Generating Revenue
9. Later Stage VC 04-Sep-2014 $85.5M $337M Completed Generating Revenue
To view Biocartis Group’s complete valuation and funding history, request access »

Biocartis Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics platform designed to support cancer diagnosis and treatment decisions. The company'
Diagnostic Equipment
Mechelen, Belgium
420 As of 2022

Yokneam Ilit, Israel
 

Liège, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biocartis Group Competitors (32)

One of Biocartis Group’s 32 competitors is PixCell Medical Technologies, a Formerly VC-backed company based in Yokneam Ilit, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PixCell Medical Technologies Formerly VC-backed Yokneam Ilit, Israel
MDxHealth Formerly VC-backed Liège, Belgium
Mindera Health Venture Capital-Backed Vista, CA
BioFire Venture Capital-Backed Salt Lake City, UT
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
You’re viewing 5 of 32 competitors. Get the full list »

Biocartis Group Patents

Biocartis Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024240872-A1 Cartridges comprising tablets Inactive 23-May-2023
EP-4701784-A1 Semi-solid phase extraction of nucleic acids using a quaternary salt and cation mixture in alkaline conditions Pending 26-Apr-2023
US-20260297555-A1 Semi-solid phase extraction of nucleic acids using a quaternary salt and cation mixture in alkaline conditions Pending 26-Apr-2023
WO-2024223814-A1 Semi-solid phase extraction of nucleic acids using a quaternary salt and cation mixture in alkaline conditions Inactive 26-Apr-2023
AU-2021367997-A1 Generic cartridge and method for multiplex nucleic acid detection Pending 29-Oct-2020 C12Q1/6823
To view Biocartis Group’s complete patent history, request access »

Biocartis Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocartis Group Investments & Acquisitions (5)

Biocartis Group’s most recent deal was a Later Stage VC with Asylia Diagnostics for . The deal was made on 18-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Asylia Diagnostics 18-Feb-2025 Later Stage VC Discovery Tools (Healthcare)
Molecular Diagnostics (Biocartis / Wondfo) 03-Sep-2018 Joint Venture Diagnostic Equipment
Pronota 04-Sep-2014 Merger/Acquisition Diagnostic Equipment
Royal Philips Electronics (Technology Platform) 10-Feb-2010 Merger/Acquisition Diagnostic Equipment
Memobead Technologies Merger/Acquisition Discovery Tools (Healthcare)
To view Biocartis Group’s complete investments and acquisitions history, request access »

Biocartis Group ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

29.87 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Biocartis Group’s complete esg history, request access »

Biocartis Group FAQs

  • When was Biocartis Group founded?

    Biocartis Group was founded in 2007.

  • Where is Biocartis Group headquartered?

    Biocartis Group is headquartered in Mechelen, Belgium.

  • What is the size of Biocartis Group?

    Biocartis Group has 420 total employees.

  • What industry is Biocartis Group in?

    Biocartis Group’s primary industry is Diagnostic Equipment.

  • Is Biocartis Group a private or public company?

    Biocartis Group is a Private company.

  • What is Biocartis Group’s current revenue?

    The current revenue for Biocartis Group is .

  • How much funding has Biocartis Group raised over time?

    Biocartis Group has raised $749M.

  • Who are Biocartis Group’s competitors?

    PixCell Medical Technologies, MDxHealth, Mindera Health, BioFire, and Hain Lifescience are some of the 32 competitors of Biocartis Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process